Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.
Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch Clin Exp Ophthalmol. 2017 Aug; 255(8):1581-1592.